Malik Fady Ibraham

Avg. Two Year Performance

No purchase track record
(7%) Avg. Sale Return
(3%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return1%< 1%(< 1%)(6%)(7%)
Sale Success Rate12 of 3910 of 397 of 392 of 392 of 39
Drugs » Biotechnology

EVP Research & Development:

Holdings: 116.92K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--